Industry News
Achilles heel found in hepatitis C virus
A vaccine and treatment for hepatitis C virus (HCV) are closer with the discovery by Australian researchers of two fatal chinks in the virus’s armour. [ + ]
Prana trial gains interest from Huntington’s disease community
International Huntington's disease patients groups have expressed strong interest in upcoming phase II trials of Prana’s treatment. [ + ]
Nominations now open for 2011 NSW Science and Engineering Awards
NSW prestigious science awards are set to be bigger and better in 2011 with three new award categories.
[ + ]First gravity wave detector step closer to development
Physicists have made a breakthrough in the development of the world’s first gravity wave detector.
[ + ]New immune cell raises prospect of asthma treatment
The suite of immune cells in the human body has increased by one, lending insight into immune responses such as asthma, and raising the possibility of a new treatment for chronic allergies. [ + ]
New chemicals causing concern at CleanUp 2011 Conference
Leading scientists will discuss concerns about the impact on human health and the environment from emerging conaminants at the CleanUp 2011 Conference in Adelaide.
[ + ]HealthLinx makes a push into Chinese market
HealthLinx has partnered with Chinese CRO with a vision to launching ovarian cancer treatment, OvPlex, into Chinese market. [ + ]
Alchemia kicks off phase II lung cancer trial
A phase II trial of anti-cancer drug, HA-Irinotecan, for the treatment of small cell lung cancer, has commenced in Melbourne. [ + ]
The Australian Innovation Challenge Awards
The Australian Innovation Challenge Awards aim to find Australia’s next big inventions in fields ranging from clean energy technology to agriculture to astronomy. Online entries close at midnight (AEST) on Wednesday 28 September.
[ + ]Thermo Fisher Scientific opens biomarker translational centre
Thermo Fisher Scientific has established a new biomarker translational centre in Cambridge Massachusetts. Their goal is to accelerate mass spectrometry-based biomarker discovery and its translation into the development of routine clinical assays for the clinical diagnostics market.
[ + ]IRL helps boost business R&D
More than 30 companies from industries as diverse as seafood, electronics, engineering and recycling have been accepted into the IRL Scientist for a Day Program aimed at helping companies across New Zealand transform their businesses.
[ + ]Feature: Building better drugs
Eureka Award winner, Associate Professor Kevin Pfleger, straddles the worlds of academia and biotechnology, helping to apply his findings for the lab to producing better drugs. [ + ]
Feature: Going rogue
Tony Purcell is using the latest in immunoproteomics technology to detect, monitor and hopefully eliminate rogue T cells that cause autoimmune disease with minimal collateral damage to the good guys. [ + ]
